Abstract
Centrally acting inhibitors of the sympathetic nervous system have been available for the treatment of hypertension for nearly 40 years. This clinical use has been limited because of the central sedative and depressive effects associated with the antihypertensive action of these drugs. The search continues for similar acting drugs that do not produce these unwanted effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Suggested Bibliography
Cressman MD. Vlasses PH: Recent issues in antihypertensive drug therapy. Med Clin North Am 1988; 72: 373–98.
Croog SH, Levine S, Testa MA, et al: The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986; 314: 1657–64.
Farsang CS: Update on methyldopa. Ther Hung 1986; 34: 139–49.
Frishman WH. Katz B: Controlled-release drug delivery system in cardiovascular disease treatment. In Cardiovascular Pharmacotherapeutics. Edited by Frishman WH, Sonnerblick EH. New York: McGraw Hill; 1997, 1363–1373.
Kaplan NM: Treatment of hypertension: drug therapy. In Kaplan NM (ed): Clinical Hypertension. Baltimore: Williams andWilkins; 1994: 211–16.
Krakoff LR: Antiadrenergic drugs with central action, ganglionic blockers, and neuron depletors. In Cardiovascular Pharmacotherapeutics. Edited by Frishman WH. Sonnenblick EH. New York: McGraw Hill; 1997, 220–227.
Leonetti G: Centrally acting antihypertensive agents. J Cardiovasc Pharmacol 1988; 12 (Suppl 8): S68–73.
Lowenthal DT, Matzek KM, MacGregor TR: Clinical phar-macokinetics of clonidine. Clin Pharmacokinet 1988; 14: 287–310.
Sorkin 13M, Heel RC: Guanfacine. Drugs 1986; 31: 301–306.
Struthers AD, Dollery CT: Central nervous system mechanism in blood pressure control. Eur J Clin Pharmacy’ 1985; 28 (Suppl):3–1 I.
Van Zwieten PA: The role of adrenoceptors in circulatory and metabolic regulation. Am Heart J 1988; 116: 1384–92.
Weber MA: Clinical pharmacology of centrally acting antihy- pertensive agents. J Clin Pharmacol 1989; 29: 698–602.
Weber MA, Draye JIM: Centrally acting antihypertensive agents: a brief overview. J Cardiovasc Pharmacol 1984; 6 (Suppl): S803–07.
Weber MA. Graethinger WF, Cheung DG: Centrally acting antihypertensive agents. In Kaplan NM, Brenner BM. Laragh JH (eds): New Therapeutic Strategies in Hypertension. New York: Raven Press; 1989: 33–50.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media New York
About this chapter
Cite this chapter
Frishman, W.H., Cheng-Lai, A., Chen, J. (2000). Alpha2-Adrenergic Agonists (Centrally Acting Antihypertensive Agents). In: Frishman, W.H., Cheng-Lai, A., Chen, J. (eds) Current Cardiovascular Drugs. Current Medicine Group, London. https://doi.org/10.1007/978-1-4615-6767-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6767-7_3
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-57340-135-7
Online ISBN: 978-1-4615-6767-7
eBook Packages: Springer Book Archive